ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc (XENE)

38.51
0.11
( 0.29% )
Updated: 10:51:14

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 132k0000000
Operating Income -38.13M-43.33M-47.37M-53.67M-53.06M-83.47M-55.84M-72.31M
Pre Tax Income -37.74M-36.26M-41.44M-47.68M-48.62M-44.95M-47.52M-58.26M
Net Income -37.15M-36.96M-41.73M-47.46M-48.46M-44.74M-47.93M-57.92M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -38.42M-41.32M-47.37M-53.67M-53.06M-83.47M-55.84M-72.31M
EBITDA -37.77M-42.82M-47.01M-53.07M-51.32M-82.62M-55.24M-71.65M
Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.8M311k06.83M32.17M18.44M9.43M0
Operating Income -24.82M-32.58M-38.02M-42.82M-31.3M-78.99M-129.14M-214.05M
Pre Tax Income -23M-30.7M-34.5M-41.62M-29.09M-78.89M-125.26M-182.69M
Net Income -23M-30.7M-34.5M-41.6M-28.01M-77.09M-124.94M-182.39M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.283-1.706-1.34-1.427-0.778-1.464-1.996-2.42
EBIT -24.82M-32.58M-33.62M-42.82M-32.29M-79.71M-132.08M-214.05M
EBITDA -23.95M-31.93M-37.43M-42.39M-30.66M-78.09M-127.52M-210.51M